Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Myelin-oligodendrocyte glycoprotein antibody-associated disease.
Marignier R, Hacohen Y, Cobo-Calvo A, Pröbstel AK, Aktas O, Alexopoulos H, Amato MP, Asgari N, Banwell B, Bennett J, Brilot F, Capobianco M, Chitnis T, Ciccarelli O, Deiva K, De Sèze J, Fujihara K, Jacob A, Kim HJ, Kleiter I, Lassmann H, Leite MI, Linington C, Meinl E, Palace J, Paul F, Petzold A, Pittock S, Reindl M, Sato DK, Selmaj K, Siva A, Stankoff B, Tintore M, Traboulsee A, Waters P, Waubant E, Weinshenker B, Derfuss T, Vukusic S, Hemmer B. Marignier R, et al. Among authors: stankoff b. Lancet Neurol. 2021 Sep;20(9):762-772. doi: 10.1016/S1474-4422(21)00218-0. Lancet Neurol. 2021. PMID: 34418402 Review.
Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
Stankoff B, Waubant E, Confavreux C, Edan G, Debouverie M, Rumbach L, Moreau T, Pelletier J, Lubetzki C, Clanet M; French Modafinil Study Group. Stankoff B, et al. Neurology. 2005 Apr 12;64(7):1139-43. doi: 10.1212/01.WNL.0000158272.27070.6A. Neurology. 2005. PMID: 15824337 Clinical Trial.
Cognitive function in radiologically isolated syndrome.
Lebrun C, Blanc F, Brassat D, Zephir H, de Seze J; CFSEP. Lebrun C, et al. Mult Scler. 2010 Aug;16(8):919-25. doi: 10.1177/1352458510375707. Epub 2010 Jul 7. Mult Scler. 2010. PMID: 20610492
Demyelination in multiple sclerosis.
Lubetzki C, Stankoff B. Lubetzki C, et al. Among authors: stankoff b. Handb Clin Neurol. 2014;122:89-99. doi: 10.1016/B978-0-444-52001-2.00004-2. Handb Clin Neurol. 2014. PMID: 24507514 Free PMC article. Review.
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
Ciccarelli O, Barkhof F, Bodini B, De Stefano N, Golay X, Nicolay K, Pelletier D, Pouwels PJ, Smith SA, Wheeler-Kingshott CA, Stankoff B, Yousry T, Miller DH. Ciccarelli O, et al. Among authors: stankoff b. Lancet Neurol. 2014 Aug;13(8):807-22. doi: 10.1016/S1474-4422(14)70101-2. Epub 2014 Jul 6. Lancet Neurol. 2014. PMID: 25008549 Review.
Recent achievements in stem cell-mediated myelin repair.
Jadasz JJ, Lubetzki C, Zalc B, Stankoff B, Hartung HP, Küry P. Jadasz JJ, et al. Among authors: stankoff b. Curr Opin Neurol. 2016 Jun;29(3):205-12. doi: 10.1097/WCO.0000000000000323. Curr Opin Neurol. 2016. PMID: 27035898 Review.
CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy.
Pignolet B, Schwab N, Schneider-Hohendorf T, Bucciarelli F, Biotti D, Averseng-Peaureaux D, Outteryck O, Ongagna JC, de Sèze J, Brochet B, Ouallet JC, Debouverie M, Pittion S, Defer G, Derache N, Hautecoeur P, Tourbah A, Labauge P, Castelnovo G, Clavelou P, Berger E, Pelletier J, Rico A, Zéphir H, Laplaud D, Wiertlewski S, Camu W, Thouvenot E, Casez O, Moreau T, Fromont A, Vukusic S, Papeix C, Vermersch P, Comabella M, Lebrun-Frenay C, Wiendl H, Brassat D; BIONAT, SFSEP, and BEST-MS networks. Pignolet B, et al. Neurology. 2016 Dec 6;87(23):2491-2494. doi: 10.1212/WNL.0000000000003401. Epub 2016 Nov 4. Neurology. 2016. PMID: 27815407 Clinical Trial. No abstract available.
Risk of relapse after natalizumab withdrawal: Results from the French TYSEDMUS cohort.
Papeix C, Vukusic S, Casey R, Debard N, Stankoff B, Mrejen S, Uhry Z, Van Ganse E, Castot A, Clanet M, Lubetzki C, Confavreux C; TYSEDMUS and OFSEP Group. Papeix C, et al. Among authors: stankoff b. Neurol Neuroimmunol Neuroinflamm. 2016 Oct 28;3(6):e297. doi: 10.1212/NXI.0000000000000297. eCollection 2016 Dec. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27844037 Free PMC article.
Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders.
Montcuquet A, Collongues N, Papeix C, Zephir H, Audoin B, Laplaud D, Bourre B, Brochet B, Camdessanche JP, Labauge P, Moreau T, Brassat D, Stankoff B, de Seze J, Vukusic S, Marignier R; NOMADMUS study group and the Observatoire Français de la Sclérose en Plaques (OFSEP). Montcuquet A, et al. Among authors: stankoff b. Mult Scler. 2017 Sep;23(10):1377-1384. doi: 10.1177/1352458516678474. Epub 2016 Nov 25. Mult Scler. 2017. PMID: 27885065
182 results